The world is changing fast and to keep up you need local knowledge with global context.
BizNews Health covers cutting-edge research, advances, opinions and debates in medicine, health and wellbeing from orthodox, complementary and alternative perspectives. We have a special focus on nutrition, fitness, longevity medicine, and prevention of non-communicable diseases – such as obesity, cancer, type 2 diabetes, heart disease and stroke, increasingly mood disorders such as depression, and dementias. We include lifestyle and travel to healthy destinations, since mind and body are integrally connected, and optimum health is not just the absence of disease, but a state of complete physical, mental, and even spiritual wellbeing.
‘One shot of Pfizer-BioNTech vaccine reduced cases among elderly and healthcare workers, according to data from rollout’, reports The Wall Street Journal.
In this episode, we speak to 32-year-old researcher Sandile Cele who has made global headlines for an important breakthrough in the fight against Covid-19.
Pfizer and BioNTech SE’s Covid-19 vaccine stimulated roughly two-thirds lower levels of neutralising antibodies against the SA variant.
We look at a breakthrough in the treatment of Covid-19 and hear about how a medication used to treat asthma appears to reduce the need for urgent care.
With SA preparing to rollout the Covid-19 vaccine, The Wall Street Journal shares insight from doctors on what to expect and how to prepare for it.
It’s a race against time to get as many people vaccinated as possible, and develop herd immunity, around the globe as the Covid-19 virus mutates.
”If you wait until a major stressor hits to try and bolster your mental health, it’s like trying to inflate your life raft while you are already drowning’.
Weight loss is a popular new year’s resolution. For those who want to lose a few “quarantine kilos” the ‘metabolic confusion’ diet might work.
Covid-19 cases breached 1 million over Christmas. An insider reports government is considering another complete alcohol ban.
The DSI has pledged R25m towards the KZN Research Innovation and Sequencing Platform to study a new Covid-19 strain.